title: NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice.
abstract: Cholestasis causes hepatocyte death, possibly because of mitochondrial injury. This study investigated whether NIM811 (N-methyl-4-isoleucine cyclosporine), an inhibitor of the mitochondrial permeability transition (MPT), attenuates cholestatic liver injury in vivo. Cholestasis was induced in mice by bile duct ligation (BDL). NIM811 was gavaged (20 mg/kg) before BDL and daily (10 mg/kg) afterward. Mitochondrial depolarization, cell death, and MPT onset were assessed by intravital confocal/multiphoton microscopy of rhodamine 123, propidium iodide, and calcein. After BDL, serum alanine aminotransferase (ALT), hepatic necrosis, and apoptosis all increased. NIM811 decreased ALT, necrosis, and apoptosis by 60 to 86%. In vehicle-treated mice at 6 h after BDL, viable hepatocytes with depolarized mitochondria were 18/high-power field (hpf), and nonviable cells were approximately 1/hpf, showing that depolarization preceded necrosis. Calcein entered mitochondria after BDL, indicating MPT onset in vivo. NIM811 decreased depolarization by 72%, prevented calcein entry into mitochondria, and blocked release of cytochrome c. Hepatic tumor necrosis factor alpha, transforming growth factor-beta1, procollagen alpha1(I) mRNA, alpha-smooth muscle actin, and Sirius red staining for collagen increased after BDL but were not different in vehicle- and NIM811-treated mice. Taken together, NIM811 decreased cholestatic necrosis and apoptosis but did not block fibrosis, indicating that the MPT plays an important role in cholestatic cell death in vivo.
authors.affiliation: Department of Pharmaceutical and Biomedical, Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Hasibur
authors.initials: H
authors.lastname: Rehman
authors.forename: Venkat K
authors.initials: VK
authors.lastname: Ramshesh
authors.forename: Tom P
authors.initials: TP
authors.lastname: Theruvath
authors.forename: Insil
authors.initials: I
authors.lastname: Kim
authors.forename: Robert T
authors.initials: RT
authors.lastname: Currin
authors.forename: Shailendra
authors.initials: S
authors.lastname: Giri
authors.forename: John J
authors.initials: JJ
authors.lastname: Lemasters
authors.forename: Zhi
authors.initials: Z
authors.lastname: Zhong
mesh_terms: D000818:Animals; D016923:Cell Death / Q000187:drug effects; D002779:Cholestasis / Q000188:drug therapy*; D003094:Collagen / Q000032:analysis; D016572:Cyclosporine / Q000494:pharmacology*; D005355:Fibrosis; D022781:Hepatocytes / Q000378:metabolism / Q000648:ultrastructure; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D051336:Mitochondrial Membranes / Q000502:physiology*; D010539:Permeability / Q000187:drug effects
chemical_list: D016572:Cyclosporine; D003094:Collagen; C090438:(melle-4)cyclosporin
references.citation: Biochem J. 1995 Apr 1;307 ( Pt 1):99-106
references.pmid: 7718000
references.citation: J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S79-84
references.pmid: 17567474
references.citation: Liver Int. 2007 Nov;27(9):1273-81
references.pmid: 17919240
references.citation: J Hepatol. 2000;32(1 Suppl):129-40
references.pmid: 10728800
references.citation: Hepatology. 2001 Mar;33(3):616-26
references.pmid: 11230742
references.citation: Free Radic Biol Med. 2000 Jan 15;28(2):251-60
references.pmid: 11281292
references.citation: Nat Rev Mol Cell Biol. 2001 Jan;2(1):63-7
references.pmid: 11413467
references.citation: FEBS Lett. 2002 Feb 13;512(1-3):1-7
references.pmid: 11852041
references.citation: Gene Ther. 2002 Feb;9(3):183-91
references.pmid: 11859421
references.citation: J Investig Med. 2002 May;50(3):193-200
references.pmid: 12033284
references.citation: Mol Pharmacol. 2002 Jul;62(1):22-9
references.pmid: 12065751
references.citation: Dig Liver Dis. 2002 Jun;34(6):387-92
references.pmid: 12132783
references.citation: Biochim Biophys Acta. 2003 Jan 20;1637(1):127-32
references.pmid: 12527417
references.citation: Lab Invest. 2003 May;83(5):655-63
references.pmid: 12746475
references.citation: Curr Med Chem. 2003 Aug;10(16):1507-25
references.pmid: 12871123
references.citation: Gastroenterology. 2003 Sep;125(3):854-67
references.pmid: 12949730
references.citation: Curr Mol Med. 2003 Sep;3(6):527-35
references.pmid: 14527084
references.citation: Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G1004-13
references.pmid: 12791596
references.citation: Nature. 2004 Jan 29;427(6973):461-5
references.pmid: 14749836
references.citation: Hepatology. 2004 Oct;40(4):998-1007
references.pmid: 15382126
references.citation: Biochim Biophys Acta. 1986 Jul 23;850(3):436-48
references.pmid: 2873836
references.citation: Biochem J. 1990 May 15;268(1):153-60
references.pmid: 2160810
references.citation: Hepatology. 2008 Jan;47(1):236-46
references.pmid: 18023036
references.citation: Physiol Rev. 2008 Jan;88(1):125-72
references.pmid: 18195085
references.citation: Gastroenterology. 1995 Oct;109(4):1249-56
references.pmid: 7557092
references.citation: J Exp Med. 1996 Apr 1;183(4):1533-44
references.pmid: 8666911
references.citation: Biochem J. 1996 Jun 15;316 ( Pt 3):765-9
references.pmid: 8670150
references.citation: Free Radic Biol Med. 1996;20(3):351-9
references.pmid: 8720905
references.citation: J Hepatol. 1997 Aug;27(2):363-70
references.pmid: 9288612
references.citation: Biochim Biophys Acta. 1998 Aug 10;1366(1-2):167-75
references.pmid: 9714791
references.citation: J Clin Invest. 1999 Jan;103(1):137-45
references.pmid: 9884343
references.citation: Semin Liver Dis. 1999;19(2):129-40
references.pmid: 10422196
references.citation: J Hepatol. 2005 Mar;42(3):378-85
references.pmid: 15710221
references.citation: Nature. 2005 Mar 31;434(7033):658-62
references.pmid: 15800627
references.citation: Gastroenterology. 2005 Jul;129(1):351-60
references.pmid: 16012960
references.citation: J Pediatr Gastroenterol Nutr. 2005 Aug;41(2):235-43
references.pmid: 16056106
references.citation: Gut. 2006 Jan;55(1):90-7
references.pmid: 16041064
references.citation: Drug Metab Dispos. 2006 Sep;34(9):1575-81
references.pmid: 16760228
references.citation: Chem Biol Interact. 2006 Oct 27;163(1-2):145-59
references.pmid: 16889760
references.citation: J Gastroenterol. 2006 Oct;41(10):971-80
references.pmid: 17096066
references.citation: Am J Transplant. 2007 May;7(5):1103-11
references.pmid: 17456198
references.citation: Arch Biochem Biophys. 2007 Jun 15;462(2):124-31
references.pmid: 17258167
references.citation: J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S73-8
references.pmid: 17567473